Evert van Velsen

Evert van Velsen is a Researcher at the Department of Internal Medicine within Erasmus University Medical Center. His work focuses on endocrinological oncology, particularly thyroid carcinoma biology and therapy, including the impact of WHO classification changes on diagnostic and treatment paradigms. He also investigates bone fragility mechanisms linked to metabolic disorders, employing advanced methodologies like Mendelian randomization.

Key research interests include radioactive iodine efficacy in differentiated thyroid cancer, molecular pathways driving radioiodine resistance, and genetic factors influencing bone health. His recent studies explore vertebral fracture risks during novel osteoporosis treatments in genetically predisposed patients.

Publications collectively highlight interdisciplinary approaches combining clinical oncology, molecular pathology, and epidemiological analysis. While no specific awards are noted, his work demonstrates significant contributions to thyroid cancer management guidelines and bone metabolism understanding.

Advising and grants: No formal advisee list appears in the provided texts. His research leverages large-scale datasets like UK Biobank, indicating collaborative grant-supported initiatives. No specific lab affiliations are mentioned beyond departmental affiliation.